ProductGuru
AI-assisted, human-edited — this page is drafted with AI from public-source data, then reviewed before publication. How we use AI →

[Recalled] RITUXAN (rituximab) - Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome - For Health Professionals — New safety information | Health Canada 2013-02-25

recall health-canada biologic-or-vaccine canada

This is an official product-safety recall record. Below are the verified details from the issuing authority, in plain language.

Recall details

ProductRITUXAN (rituximab) - Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome - For Health Professionals
CategoryBiologic or vaccine
Issuing authorityHC
Reference48959
Country of noticeCanada
Hazard typerecall
Notice date25 February 2013

Why it was recalled

According to the HC notice, the identified hazard is: New safety information

This safety recall concerns Biologic or vaccine products distributed in Canada and was recorded by HC. Recalls in this category are published so that owners, retailers, and importers can identify affected units and act quickly.

What to do if you own this product

Review the official notice to confirm whether your unit is affected.

Read the full official notice →

This page indexes a public government recall notice for reference. We do not sell or verify this product; always confirm the current status on the authority's official site.

Shop Recalled RITUXAN rituximab Toxic
Search on Amazon ›Find on eBay ›
As an Amazon Associate and eBay Partner, we may earn from qualifying purchases.
Related articles

Explore by topic

Looking up a product? Use ProductGuru — free barcode & product database with 35M+ products. Search by EAN / UPC barcode.
Was this page helpful?